"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
In chronic myelogenous leukemia (CML), the leukemia cell that starts the disease makes blood cells (red cells, white cells and platelets) that function almost like normal cells.
在慢粒中，起始的白血病细胞产生功能正常的血细胞(红细胞、白细胞、血小板)。
Objective to investigate the effect of autologous dendritic cells (DC) to activate t lymphocytes and purify bone marrow of chronic myelogenous leukemia (CML).
目的考察慢性粒细胞白血病(cml)树突状细胞(DC)刺激自体骨髓t细胞，清除白血病细胞的作用。
The drug blocks a mutant protein that causes chronic myelogenous leukemia (CML), becoming the first chemotherapy to specifically target cancer cells.
该药可以阻断引起慢性髓细胞性白血病（CML）的突变蛋白，成为第一个特异靶向癌细胞的化学药。
The drug blocks a mutant protein that causes chronic myelogenous leukemia (CML), becoming the first chemotherapy to specifically target cancer cells.
该药可以阻断引起慢性髓细胞性白血病（CML）的突变蛋白，成为第一个特异靶向癌细胞的化学药。
应用推荐